CClinicalTrials.gg
CompletedNCT05059171Updated Sep 28, 2021

Postoperative Pain of Rotary Versus Reciprocating Motions of Two Single Files

An interventional study of OneSahpe single file and WaveOne Gold single file in Postoperative Pain, sponsored by Minia University. Completed at 1 site in Egypt. Open to participants aged 4 Years to 8 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-28.

Sponsored by Minia University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Nov 2020, registered Sep 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
260
Allocation
Randomized
Ages
4 Years to 8 Years
Sex
All
01

Study summary

An equivalent parallel randomized clinical trial was approved by the local University Committee of Ethics. 260 children with necrotic primary molars were allocated into 2 equal groups (82 children per group). The participants were allocated into two groups; group "1" teeth were instrumented with OneShape rotary system (Micro Mega, Besancon, France), and group "2" teeth were instrumented with WaveOne Gold reciprocating system (Dentsply Maillefer, Ballaigues, Switzerland). Postoperative pain was assessed using a four-point pain intensity rating scale adopted from Wong-Baker FACES (WBF) pain scale . The face scale consists of four faces with a brief title describing each face representing a scale from the first face (score 1), second face (score 2), third face (score 3), and forth face (score 4) 3. Postoperative pain was assessed at 6 six time intervals (at 6, 12, 24, 48, 72 hours and one-week).

02

Conditions studied

  • Postoperative Pain

Browse trials for

03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 260 is above the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Minia University is the lead sponsor of 356 studies on the registry; 115 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 8 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Children ages from 4 to 8 years classified as class I or II according to the American Society of Anesthesiologists (ASA).
  2. No previous dental experience.
  3. Non-vital primary molar (necrotic or with chronic apical periodontitis) which confirmed radiographicly with the presence or absence of periapical radiolucency.
  4. Severe tooth mobility.

Exclusion criteria

Exclusion Criteria:

  1. Severe behaviour or emotional disabilities.
  2. Analgesic intake in the preceding 12 hours.
  3. Non-restorable crowns of primary molars.
  4. Radiographic presence of internal root resorption or massive bone destruction.
  5. Root resorption exceeded one-third of the root length.

    -

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
260 participants (actual)

Study arms

  • Active comparator
    Rotary motion using OneShape single file

    File size 25 with a taper of 0.06 was mounted to a 6:1 speed-reduction headpiece powered by X Smart Plus endomotor (Dentsply Maillefer, Ballaigues, Switzerland). The speed and torque were set to 400 rpm and 1 N.cm torque, respectively. In a picking motion without pressure, mechanical preparation began with the first RC two-thirds followed by the next 3 mm followed by the full WL.

    Device: OneSahpe single file

  • Active comparator
    Reciprocating motion using WaveOne Gold single file

    A Primary file size 25 a taper of 0.07 was installed to pre-programmed reciprocation angles and speed for the WaveOne system handpiece of an endomotor (X Smart Plus endomotor (Dentsply Maillefer, Ballaigues, Switzerland). After ensuring a passive fit of the hand file along the predetermined WL, the RC coronal two-thirds was initially instrumented then followed by the full WL.

    Device: WaveOne Gold single file

Interventions

  • DeviceOneSahpe single file

    The rotary motion of OneShape single file

  • DeviceWaveOne Gold single file

    reciprocation motions of WaveOne Gold single file

06

What researchers measure

Primary outcomes

  1. Postoperative pain

    Postoperative pain was assessed using a four-point pain intensity rating scale adopted from Wong-Baker FACES (WBF) pain scale . The face scale consists of four faces with a brief title describing each face representing a scale from the first face (score 1), second face (score 2), third face (score 3), and fourth face (score 4) 17. Postoperative pain was assessed at 6 six time intervals

    Time frame: One week

07

Study locations

1 site
  • Ngwa Khattab
    Minya, Minia 61111, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05059171
Lead sponsor
Minia University
Responsible party
Ahmad Elheeny (Associate Professor, Minia University) — Principal investigator
First posted
Sep 28, 2021
Start date
Nov 16, 2020
Primary completion
Aug 31, 2021
Completion
Aug 31, 2021
Last update
Sep 28, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion